tiprankstipranks
Iterum Therapeutics Plc (ITRM)
NASDAQ:ITRM
US Market

Iterum Therapeutics (ITRM) Income Statement

Compare
869 Followers

Iterum Therapeutics Income Statement

Last quarter (Q4 2024), Iterum Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Iterum Therapeutics's net income was $-6.58M. See Iterum Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -254.00K$ -1.75M$ -1.80M$ -2.10M$ -161.00K
Operating Expenses
$ 18.44M$ 47.47M$ 30.38M$ 24.54M$ 32.13M
Depreciation and Amortization
$ 0.00$ 1.75M$ 1.80M$ 2.10M$ 161.00K
EBITDA
$ -18.70M$ -34.58M$ -39.97M$ -83.20M$ -36.01M
Operating Income
$ -18.70M$ -47.47M$ -30.38M$ -24.54M$ -32.13M
Other Income/Expenses
$ -5.84M$ 9.71M$ -13.75M$ -66.32M$ -19.14M
Pretax Income
$ -24.53M$ -37.76M$ -44.13M$ -90.86M$ -51.26M
Net Income
$ -24.77M$ -38.37M$ -44.43M$ -91.56M$ -52.01M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.26$ -2.96$ -3.63$ -0.56$ -2.17
Diluted EPS
$ -1.26$ -2.96$ -3.63$ -0.56$ -2.17
Weighted Average Shares Outstanding
19.70M 12.96M 12.24M 163.37M 24.01M
Weighted Average Shares Outstanding (Diluted)
19.70M 12.96M 12.24M 163.37M 24.01M
Currency in USD

Iterum Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis